A M Castellano-Guerrero1, R Guerrero1,2, F Relimpio1,2, F Losada1,2, M A Mangas1,2, A Pumar1,2, M A Martínez-Brocca3,4. 1. Unidad de Gestión Clínica de Endocrinología y Nutrición, Hospital Universitario Virgen del Rocío, Seville, Spain. 2. Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/Consejo Superior de Investigaciones Científicas/Universidad de Sevilla, Seville, Spain. 3. Unidad de Gestión Clínica de Endocrinología y Nutrición, Hospital Universitario Virgen Macarena, Seville, Spain. masuncion.martinez.sspa@juntadeandalucia.es. 4. Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/Consejo Superior de Investigaciones Científicas/Universidad de Sevilla, Seville, Spain. masuncion.martinez.sspa@juntadeandalucia.es.
Abstract
AIMS: To determine gender and age differences in the prevalence of depression and anxiety and their predictive factors in adult patients with type 1 diabetes (DM1). METHODS: Random sample of DM1 adult patients from a tertiary care hospital cohort. To evaluate the presence of depression and anxiety, psychological evaluation was performed using structured clinical interview (MINI). For the specific evaluation of fear of hypoglycemia (FH), FH-15 questionnaire was used. RESULTS: 339 patients [51.6% male; 38.5 ± 12.9 years; HbA1c 7.5 ± 1.1% (58.5 ± 14.2 mmol/mol); 20.1 ± 12.0 years of DM1] met the inclusion criteria. Prevalence of depression, anxiety, and FH in men vs. women was as follows (%): depression: 15.4 vs. 33.5 (p < 0.05); anxiety: 13.7 vs. 26.2 (p < 0.05); and FH: 42.8 vs. 46.0 (p = NS). Among midlife female patients, prevalence of depression and anxiety was higher compared to male. Moreover, comorbid depressive and anxious symptoms were also higher in midlife female patients compared to age-matched male patients (3.5 vs. 14%, p < 0.05). Apart from age-related vulnerability, female gender, poor glycemic control, and microvascular and macrovascular complications were predictive factors for depressive and anxious symptomatology. Unawareness hypoglycemia and anxiety-prone personality were predictor factors for FH. CONCLUSIONS: In adults with DM1, prevalence of depression and anxiety is higher in women. Midlife patients, in particular women, show a significantly higher prevalence of anxiety symptoms and comorbid depression and anxiety. The presence of secondary complications and sustained poor glycemic control should alert to the possibility of these mental disorders, especially in the most vulnerable age population; clinical, gender and age-related patterns could help to design more effective psychological assessment and support in adult patients with DM1.
AIMS: To determine gender and age differences in the prevalence of depression and anxiety and their predictive factors in adult patients with type 1 diabetes (DM1). METHODS: Random sample of DM1 adult patients from a tertiary care hospital cohort. To evaluate the presence of depression and anxiety, psychological evaluation was performed using structured clinical interview (MINI). For the specific evaluation of fear of hypoglycemia (FH), FH-15 questionnaire was used. RESULTS: 339 patients [51.6% male; 38.5 ± 12.9 years; HbA1c 7.5 ± 1.1% (58.5 ± 14.2 mmol/mol); 20.1 ± 12.0 years of DM1] met the inclusion criteria. Prevalence of depression, anxiety, and FH in men vs. women was as follows (%): depression: 15.4 vs. 33.5 (p < 0.05); anxiety: 13.7 vs. 26.2 (p < 0.05); and FH: 42.8 vs. 46.0 (p = NS). Among midlife female patients, prevalence of depression and anxiety was higher compared to male. Moreover, comorbid depressive and anxious symptoms were also higher in midlife female patients compared to age-matched male patients (3.5 vs. 14%, p < 0.05). Apart from age-related vulnerability, female gender, poor glycemic control, and microvascular and macrovascular complications were predictive factors for depressive and anxious symptomatology. Unawareness hypoglycemia and anxiety-prone personality were predictor factors for FH. CONCLUSIONS: In adults with DM1, prevalence of depression and anxiety is higher in women. Midlife patients, in particular women, show a significantly higher prevalence of anxiety symptoms and comorbid depression and anxiety. The presence of secondary complications and sustained poor glycemic control should alert to the possibility of these mental disorders, especially in the most vulnerable age population; clinical, gender and age-related patterns could help to design more effective psychological assessment and support in adult patients with DM1.
Entities:
Keywords:
Age difference; Anxiety; Depression; Fear of hypoglycemia; Gender differences; Type 1 diabetes mellitus
Authors: Ana María Castellano-Guerrero; Raquel Guerrero; Desireé Ruiz-Aranda; Sofia Perea; Alfonso Pumar; Federico Relimpio; Miguel Angel Mangas; Fernando Losada; Maria Asunción Martínez-Brocca Journal: Diabetol Metab Syndr Date: 2020-07-17 Impact factor: 3.320
Authors: Azubuike P Ebokaiwe; Stephen Okori; Joseph O Nwankwo; Chukwunonso E C C Ejike; Sharon O Osawe Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 2020-10-16 Impact factor: 3.000
Authors: Mónica Carreira; María Soledad Ruiz de Adana; Marta Domínguez; Sergio Valdés; Maria Cruz Almaraz; Gabriel Olveira; María Teresa Anarte Journal: Int J Environ Res Public Health Date: 2021-11-28 Impact factor: 3.390
Authors: Marta Lopez-Herranz; Rodrigo Jiménez-García; Zichen Ji; Javier de Miguel-Diez; David Carabantes-Alarcon; Clara Maestre-Miquel; José J Zamorano-León; Ana López-de-Andrés Journal: Int J Environ Res Public Health Date: 2021-06-04 Impact factor: 3.390